Stay updated on Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new NIH grant/contract line was added under Other Study ID Numbers. The page revision has been updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T18:38:05.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.6.5 replaces v3.6.4 in the page, indicating a software version update. This signals a software update and does not alter the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T18:17:38.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page's revision tag was updated to Revision: v3.6.4, replacing the previous v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-25T11:41:17.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Page revision label updated from v3.6.2 to v3.6.3. This indicates a small editorial/technical update to the page, without changing study content or outcomes.
    Difference
    0.1%
    Check dated 2026-07-04T03:47:57.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.6.2, replacing Revision: v3.6.0; this reflects a platform update and does not change the study details displayed.
    Difference
    0.1%
    Check dated 2026-06-26T23:47:33.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Adds a recruitment status notice stating that no participants are being recruited, signaling the study is closed to enrollment. Also introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the page revision from v3.5.5 to v3.6.0 with a formatting change to the Intervention/Treatment header.
    Difference
    0.4%
    Check dated 2026-06-12T16:30:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.